Viewing Study NCT07215806

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 11:00 AM

Ignite Modification Date: 2025-12-29 @ 4:45 PM

Study NCT ID: NCT07215806

Status: COMPLETED

Last Update Posted: 2025-11-14

First Post: 2025-10-08

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module